Clinical Trials on Lymphoma, B-Cell in Switzerland

Total 883 results

NovoCure Ltd.

Completed

NovoTTF-100L in Combination With Pemetrexed (Alimta®) for Advanced Non-small Cell Lung Cancer

NSCLC | Non-small Cell Lung Cancer

Switzerland
Novartis Pharmaceuticals

Completed

A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma

Metastatic Melanoma and Merkel Cell Carcinoma

Germany, Switzerland
University Hospital Inselspital, Berne

Completed

Lymph Node Identification in Skin Malignancy Using ICG Transcutaneously Study (LIMIT)

Merkel Cell Carcinoma | Malignant Melanoma

Switzerland
Swiss Group for Clinical Cancer Research
Nordic Lymphoma Group

Terminated

Rituximab With or Without Ibrutinib for Patients With Advanced Follicular Lymphoma

Follicular Lymphoma

Sweden, Finland, Denmark, Norway, Switzerland, Austria
Amgen

Completed

Phase 3 Trial of Blinatumomab vs Standard Chemotherapy in Pediatric Subjects With HIgh-Risk (HR) First Relapse B-precursor Acute Lymphoblastic Leukemia (ALL)

Leukemia, Acute Lymphoblastic

Italy, United Kingdom, Belgium, Mexico, Germany, Russian Federation, Turkey, Spain, Australia, Poland, Austria, Czechia, France, Portugal, Israel, Denmark, Brazil, Romania, Sweden, Switzerland, Norway, Netherlands, Argentina, Greece
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; University of Bern

Recruiting

Magrolimab in Combination With Cytotoxic Chemotherapy in Advanced Urothelial Carcinoma (MACOCUC-01)

Advanced Urothelial Carcinoma

Switzerland
European Organisation for Research and Treatment...

Completed

Combination Chemotherapy in Treating Older Patients With Non-Hodgkin's Lymphoma

Lymphoma

France, Netherlands, Belgium, United Kingdom, Egypt, Switzerland, Portugal
Novartis Pharmaceuticals

Completed

A Trial to Evaluate the Safety, Local Tolerability, Pharmacokinetics and Pharmacodynamics of LDE225 on Skin Basal Cell Carcinomas in Gorlin Syndrome Patients

Treatment for Basal Cell Carcinomas (BCCs) in Gorlin Syndrome Patients

Austria, Switzerland
University Hospital, Basel, Switzerland

Completed

Manufacture of Clinical T-cell Products for Future Treatment

Virus-specific T Cells

Switzerland
Felix Beuschlein
Radboud University Medical Center; University of Zurich; Ludwig-Maximilians -... and other collaborators

Recruiting

Multicenter Pheochromocytoma and Paraganglioma Evaluation (MUPPET)

Pheochromocytoma | Paraganglioma

Switzerland
Ipsen

Completed

68Ga-OPS202 Study for Diagnostic Imaging of GEP NET

Gastroenteropancreatic Neuroendocrine Tumors

Switzerland
ADC Therapeutics S.A.

Terminated

Study to Evaluate the Efficacy and Safety of Loncastuximab Tesirine Versus Idelalisib in Participants With Relapsed or Refractory Follicular Lymphoma (LOTIS-6)

Relapsed Follicular Lymphoma | Refractory Follicular Lymphoma

United States, Belgium, Hungary, Israel, Spain, Switzerland, Poland, France, United Kingdom, Italy
Kai-Uwe Schmitt, PhD, MEng, ICID

Recruiting

Digital Lifestyle Intervention for Lung Cancer Survivors After Inpatient Rehabilitation (QUALUCA)

Non-Small Cell Lung Cancer (NSCLC)

Switzerland
Prof. Dr. Silke Gillessen

Terminated

Phase I/II Study of Vaccination With Antigen Loaded Dendritic Cells (DCs) in Patients With Inoperable Stage III and Stage IV Melanoma

Melanoma

Switzerland
University of Lausanne Hospitals
Fond'action contre le cancer; Barletta Foundation; NCCR (National Center of Competence...

Suspended

Adoptive Cell Transfer Combined With Peptide Vaccination in Transiently Immunosuppressed Melanoma Patients

Melanoma

Switzerland
University of Zurich

Completed

Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel

Melanoma

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Circulating Tumor Cells (CTC) in Cancer

Cancer

Switzerland
University Hospital, Basel, Switzerland
Anaveon AG

Recruiting

ACT-TIL and ANV419 for Advanced Melanoma. (BaseTIL-03M)

Advanced Melanoma

Switzerland
Centre Hospitalier Universitaire Vaudois

Completed

Sorafenib and Radioembolization With Sir-Spheres® for the Treatment of Metastatic Ocular Melanoma

Ocular Melanoma

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Binimetinib in Addition to Standard Chemotherapy in KRAS Mutated NSCLC.

Lung Cancer | KRAS Gene Mutation | Advanced Non-small Cell Lung Cancer

Switzerland
University of Zurich

Completed

Ambulatory Physical Exercise Program in Hematopoietic Stem Cell Transplantation Recipients

Hematopoietic Stem Cell Transplantation

Switzerland, Netherlands
Hoffmann-La Roche

Completed

A Pharmacokinetic and Metabolism Study of 14C-labeled RO5185426 on Patients With Metastatic Melanoma

Malignant Melanoma

Switzerland
University of Zurich

Completed

Ipilimumab-induced Lung Toxicity: Observational Study (Ipi-Lu-Tox)

Metastatic Melanoma

Switzerland
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Philogen S.p.A.

Recruiting

Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma (GLIOSUN)

Glioblastoma

Switzerland
University Hospital Inselspital, Berne

Completed

TAF for HIV-HBV With Renal Dysfunction

HIV and Hepatitis B Coinfection

Switzerland
University of Zurich

Completed

Avastin Plus Radiotherapy in Elderly Patients With Glioblastoma (ARTE)

Glioblastoma

Switzerland
University of Zurich

Unknown

Combined Approach to Resection of Glioblastoma (GBM) by 5-Aminolevulinic Acid (5-ALA) and Intraoperative Magnetic Resonance Imaging (MRI)

Glioblastoma

Switzerland
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer

Juvenile Myelomonocytic Leukemia | Chronic Lymphocytic Leukemia | Secondary Acute Myeloid Leukemia | Childhood Acute Lymphoblastic Leukemia | Prolymphocytic Leukemia | Hairy Cell Leukemia | Acute Undifferentiated Leukemia | Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative | Childhood Acute Myeloid... and other conditions

United States, Canada, Australia, New Zealand, Puerto Rico, Switzerland
University Hospital Inselspital, Berne

Completed

Impact of Excision Margins on Survival and Recurrence Rate in Patients With Thick Melanoma (>2mm)

Melanoma

Switzerland
University Hospital, Basel, Switzerland
Novartis; Schweizerische Stiftung für die Erforschung der Muskelkrankheiten

Recruiting

Predictive Factors for Treatment Response in Patients With Newly-diagnosed Polymyalgia Rheumatica and Giant Cell Arteritis

Polymyalgia Rheumatica (PMR) | Giant Cell Arteritis (GCA)

Switzerland
University Hospital, Geneva
Prof Laurent Kaiser; Dr Samuel Cordey; Dr Stavroula Masouridi-Levrat; Prof Christian... and other collaborators

Completed

DNA and RNA Viruses of the Blood Virome of Allogeneic Hematopoietic Stem Cell Transplant Recipients (GeBVir)

RNA Virus Infections | DNA Virus Infections | Hematopietic Stem Cell Transplantation | Blood Virome

Switzerland
PIQUR Therapeutics AG
University Hospital Inselspital, Berne; University Hospital, Basel, Switzerland and other collaborators

Terminated

Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients

Glioblastoma Multiforme

Switzerland
Swiss Group for Clinical Cancer Research

Completed

Temozolomide and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery

Melanoma (Skin)

Switzerland
Prof. Serge Leyvraz

Completed

Cyclophosphamide and Fludarabine Followed by Cellular Adoptive Immunotherapy and Vaccine Therapy in Patients With Metastatic Melanoma

Melanoma (Skin)

Switzerland
University Hospital, Geneva

Unknown

Lung Cancer Rehabilitation Study (LCRS)

Non Small Cell Lung Cancer

Switzerland
Centre Hospitalier Universitaire Vaudois
Ludwig Institute for Cancer Research

Completed

Immunotherapy of HLA-A2 Positive Stage III/IV Melanoma Patients

Melanoma

Switzerland
John O. Prior

Terminated

Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma (Tilmanocept)

Melanoma

Switzerland
Centre Hospitalier Universitaire Vaudois
Immutep S.A.S.

Terminated

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients (LAG-3/IMP321)

Melanoma

Switzerland
Cristiana Sessa

Completed

Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor (IOSI-NDU-001)

Breast Cancer | NSCLC | Endometrial Cancer | Ovary Cancer | Small Cell Lung Cancer (SCLC) | Head and Neck (HNSCC)

Switzerland
University Hospital, Basel, Switzerland
Swiss National Science Foundation; Paul Scherrer Institute (PSI)

Recruiting

Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3) (Beta plus)

Neuroendocrine Neoplasia's (NENs) | Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Switzerland
University of Zurich

Unknown

Temozolomide vs. Temozolomide and Thalidomide Treatment in Recurrent Glioblastoma

Glioblastoma

Switzerland
Ente Ospedaliero Cantonale, Bellinzona
Neurocenter of Southern Switzerland; Istituto Cantonale di Patologia

Recruiting

Glioma Brain Tumours - E12513 - SensiScreen Glioma

Glioma

Switzerland
University Hospital, Geneva
Hospices Civils de Lyon; University Hospital, Toulouse

Recruiting

Hyperbaric-oxygen Therapy (HBOT) Versus Placebo for Treating Vaso-Occlusive Crisis (VOC) in Sickle Cell Disease (SCD) (HBOT-SCD)

Sickle Cell Disease | Vaso-occlusive Crisis | Hyperbaric Oxygen Therapy

France, Switzerland
University of Zurich

Completed

Monocentric Pilot Study Investigating the Metabolic Activity of Melanoma in Vivo During Sorafenib and Dacarbazine

Melanoma Stage III or IV | No Prior Chemotherapy

Switzerland
University of Zurich

Completed

Closed vs. Open Face Masks for Cranial Radiotherapy

Small Cell Lung Cancer | Brain Tumor | Meningioma | Brain Metastases

Switzerland
University Hospital, Basel, Switzerland

Active, not recruiting

Neuroendocrine Neoplasms Methylation Based Classifier - The NEMESIs-study (NEMESIs)

Neuroendocrine Tumors

Switzerland
University of Lausanne Hospitals
Lionel Perrier Foundation (Montreux, Switzerland)

Completed

Multimodal Diagnostic Assessment of Cerebral Gliomas With FET & FCH PET/CT, and Magnetic Resonance Imaging/Spectroscopy (Gliomes-FLP)

Glioma

Switzerland
Centre Hospitalier du Centre du Valais
University of Lausanne Hospitals; Research Unit CHCVs Hôpital de Sion Switzerland and other collaborators

Unknown

Effects of High Cut-off (HCO) Hemodialysis on Central Memory CD4+ T and Treg Cells in Patients With End-stage Kidney Disease

End-stage Kidney Disease | CD4 T Cells | Central Memory T Cells | Regulatory T Cells | Uremic Toxins

Switzerland
University Hospital, Basel, Switzerland
University Basel, Department of Sport, Exercise and Health, Division of Sport...

Completed

Glioma and Exercising

High Grade Glioma

Switzerland

Clinical Trials on Lymphoma, B-Cell in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations